Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
03 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250403148958/en/Blackstone-Life-Sciences-and-Anthos-Therapeutics-Announce-Novartis-has-Completed-the-Acquisition-of-Anthos-Therapeutics-in-a-Deal-Valued-at-up-to-%243.1B-with-%24925M-Paid-Upfront
29 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/29/3051766/0/en/Anthos-Therapeutics-Shares-New-Data-from-the-Landmark-AZALEA-TIMI-71-Study-Demonstrating-the-Factor-XI-Inhibitor-Abelacimab-Significantly-Reduced-Bleeding-in-Patients-Regardless-of.html
12 Feb 2025
// REUTERS
https://www.reuters.com/markets/deals/novartis-agrees-acquire-anthos-up-31-bln-2025-02-11/
11 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/11/3023892/0/en/Novartis-bolsters-late-stage-cardiovascular-pipeline-with-agreement-to-acquire-Anthos-Therapeutics-for-USD-925-million-upfront.html
22 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/22/3013921/0/en/Data-Published-Today-in-the-New-England-Journal-of-Medicine-Demonstrates-Anthos-Therapeutics-novel-Factor-XI-inhibitor-Abelacimab-150mg-Reduced-Major-or-Clinically-Relevant-Non-Maj.html
16 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/16/2982367/0/en/Anthos-Therapeutics-Shares-New-Analysis-from-the-Landmark-AZALEA-TIMI-71-Study-Demonstrating-the-Factor-XI-Inhibitor-Abelacimab-Substantially-Reduced-Bleeding-in-Patients-on-Antipl.html
ABOUT THIS PAGE